Cited by 82Neuroscience and Neuropharmacology ResearchMemory and Neural MechanismsAmino Acid Enzymes and Metabolism

Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level

Open access
Li, Yan, Sacchi, Silvia, Pollegioni, Loredano, Basu, Alo C., Coyle, Joseph T., Bolshakov, Vadim Y.·2013·Nature Communications

Abstract

Mechanisms of N-methyl-D-aspartate receptor-dependent synaptic plasticity contribute to the acquisition and retention of conditioned fear memory. However, synaptic rules which may determine the extent of N-methyl-D-aspartate receptor activation in the amygdala, a key structure implicated in fear learning, remain unknown. Here we show that the identity of the N-methyl-D-aspartate receptor glycine site agonist at synapses in the lateral nucleus of the amygdala may depend on the level of synaptic activation. Tonic activation of N-methyl-D-aspartate receptors at synapses in the amygdala under low activity conditions is supported by ambient D-serine, whereas glycine may be released from astrocytes in response to afferent impulses. The release of glycine may decode the increases in afferent activity levels into enhanced N-methyl-D-aspartate receptor-mediated synaptic events, serving an essential function in the induction of N-methyl-D-aspartate receptor-dependent long-term potentiation in fear conditioning pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms2779

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Published studies have revealed beneficial effects of NAC in schizophrenia patients as an add-on to maintenance medication.

    “Published studies have revealed beneficial effects in schizophrenia patients as an add-on to maintenance medication [100][101][102][103] and ongoing studies are following up their results and including additional metrics of efficacy such as brain GSH imaging in order to reflect the BBB permeability analyses of NAC that have been performed in rodents 104 .”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 52 · Cited by 82

Authors
Li, Y., Sacchi, S., Pollegioni, L., Basu, A. C., Coyle, J. T., & Bolshakov, V. Y.
Affiliations
  • Harvard University (US)
  • University of Insubria (IT)
Corresponding author
Bolshakov, Vadim Y.
Venue
Nature Communications
Published
2013-04-23
Volume
4
Issue
1
Pages
1760-1760
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2114197624
Cited by
82
References
52
Citations by year
2025: 3 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 7 · 2019: 8 · 2018: 5 · 2017: 11 · 2016: 11 · 2015: 6 · 2014: 8 · 2013: 3
FWCI
4.58
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • IrInSubria (University of Insubria) (submittedVersion)
Funders
  • National Alliance for Research on Schizophrenia and Depression
  • Ministero dell’Istruzione, dell’Università e della Ricerca (2008N2FM4A_001)
  • National Institutes of Health (W81XWH)
  • National Institute of Mental Health (R01MH090464, P50MH060450, R01MH051290, MH083011, MH051290, R21MH083011, MH060450, MH090464)
  • U.S. Army Medical Research Acquisition Activity
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
NMDA receptor, lateral amygdala, D-serine, glycine release, astrocytes, synaptic activity, fear conditioning, long-term potentiation, synaptic plasticity, glutamate
MeSH terms
Amygdala, Animals, Astrocytes, D-Amino-Acid Oxidase, Female, Gliotoxin, Glycine, Male, Serine, Synapses, Receptors, N-Methyl-D-Aspartate, Rats, Sprague-Dawley, Long-Term Potentiation, Excitatory Postsynaptic Potentials, Mice, Rats, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review